(NASDAQ: HSIC) Henry Schein's forecast annual revenue growth rate of 5.21% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 56.5%.
Henry Schein's revenue in 2026 is $12,938,000,000.On average, 18 Wall Street analysts forecast HSIC's revenue for 2026 to be $1,625,308,685,442, with the lowest HSIC revenue forecast at $1,550,317,983,383, and the highest HSIC revenue forecast at $1,689,350,980,450. On average, 16 Wall Street analysts forecast HSIC's revenue for 2027 to be $1,686,643,309,889, with the lowest HSIC revenue forecast at $1,597,290,181,376, and the highest HSIC revenue forecast at $1,765,518,930,579.
In 2028, HSIC is forecast to generate $1,744,917,089,354 in revenue, with the lowest revenue forecast at $1,676,283,526,873 and the highest revenue forecast at $1,796,245,105,206.